# clm_F14A51AD91E7

subject: Gilead Sciences (/record/gilead-sciences.md)  
predicate: total_equity  
value: 18,475,000,000 United States dollar  
valid_from: 2024-09-30  
valid_to: 2024-12-31  
published: 2024-11-12  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_4AF8C0C466F3  
last_updated: 2026-11-08  
cite: AsOf. "Gilead Sciences total equity: 18,475,000,000 United States dollar", as of 2024-09-30 (until 2024-12-31). Claim clm_F14A51AD91E7, https://asof.is/claim/clm_F14A51AD91E7, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/882095/000088209524000028/0000882095-24-000028-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:StockholdersEquity in 10-Q Q3 FY2024, filed 2024-11-12  

## Sources

- https://www.sec.gov/Archives/edgar/data/882095/000088209524000028/0000882095-24-000028-index.htm (primary, SEC EDGAR 10-Q Q3 FY2024, published 2024-11-12)

## Supersedes

- [Gilead Sciences](/record/gilead-sciences.md) | total_equity | 18,281,000,000 United States dollar | valid 2024-06-30 to 2024-09-30 | conf 0.95 | superseded | superseded_by [clm_F14A51AD91E7](/claim/clm_F14A51AD91E7.md) | [clm_7EE809D238E0](/claim/clm_7EE809D238E0.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.